Phase II study of carboxyamidotriazole (CAI NSC #609974) [L 651582] in patients with advanced renal cell carcinoma refractory to immunotherapy.
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2009
At a glance
- Drugs L 651582 (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 26 Oct 2006 New trial record.